controlled-trials.com/ISRCTN06473203, previous seen December Twelve, This year). If a tumour includes several subclones which may be spatially split up, just how can the particular subclone which has the dominating influence insofar as therapeutic end result end up being determined? In addition, it will be logical to suggest that much more heterogeneous cancer will have one of these simple


Who Upvoted this Story